Guardant and MSD will evaluate opportunities to develop new oncology therapies using liquid biopsy tests.

SK bioscience announced that it is advancing the development of a Zaire ebolavirus vaccine under a new collaboration ...

MSD and the Coalition for Epidemic Preparedness Innovations have launched a $30 million initiative to improve the ...

MSD awaits 20 potential launches and 80 late-stage readouts across its pipeline, which it believes will double $35bn ...

Jan 21 (Reuters) - Merck & Co unit MSD and the Coalition for Epidemic Preparedness Innovations said on Wednesday they have ...

MSD's cancer immunotherapy Keytruda will soon be available as a subcutaneous injection that does away with the need to visit an infusion clinic. Keytruda Qlex (pembrolizumab and berahyaluronidase alfa ...

MSD and Moderna have kicked off another phase 3 trial of their personalised cancer vaccine V940 used alongside MSD's PD-1 inhibitor Keytruda, this time focusing on patients with earlier-stage ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. Correction: This script has been updated ...